It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
GMED’s FA Score shows that 0 FA rating(s) are green whileTELA’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
GMED’s TA Score shows that 6 TA indicator(s) are bullish while TELA’s TA Score has 3 bullish TA indicator(s).
GMED (@Medical/Nursing Services) experienced а -1.09% price change this week, while TELA (@Medical/Nursing Services) price change was -10.67% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -0.02%. For the same industry, the average monthly price growth was +4.22%, and the average quarterly price growth was +24.21%.
GMED is expected to report earnings on Nov 11, 2025.
TELA is expected to report earnings on Nov 05, 2025.
The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
GMED | TELA | GMED / TELA | |
Capitalization | 8.18B | 63M | 12,990% |
EBITDA | 620M | -34.73M | -1,785% |
Gain YTD | -26.732 | -47.351 | 56% |
P/E Ratio | 23.49 | N/A | - |
Revenue | 2.63B | 75.3M | 3,487% |
Total Cash | 229M | 35M | 654% |
Total Debt | 121M | 41.9M | 289% |
GMED | TELA | ||
---|---|---|---|
OUTLOOK RATING 1..100 | 50 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 73 Overvalued | 39 Fair valued | |
PROFIT vs RISK RATING 1..100 | 90 | 100 | |
SMR RATING 1..100 | 76 | 100 | |
PRICE GROWTH RATING 1..100 | 57 | 86 | |
P/E GROWTH RATING 1..100 | 100 | 100 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
TELA's Valuation (39) in the null industry is somewhat better than the same rating for GMED (73) in the Medical Specialties industry. This means that TELA’s stock grew somewhat faster than GMED’s over the last 12 months.
GMED's Profit vs Risk Rating (90) in the Medical Specialties industry is in the same range as TELA (100) in the null industry. This means that GMED’s stock grew similarly to TELA’s over the last 12 months.
GMED's SMR Rating (76) in the Medical Specialties industry is in the same range as TELA (100) in the null industry. This means that GMED’s stock grew similarly to TELA’s over the last 12 months.
GMED's Price Growth Rating (57) in the Medical Specialties industry is in the same range as TELA (86) in the null industry. This means that GMED’s stock grew similarly to TELA’s over the last 12 months.
GMED's P/E Growth Rating (100) in the Medical Specialties industry is in the same range as TELA (100) in the null industry. This means that GMED’s stock grew similarly to TELA’s over the last 12 months.
GMED | TELA | |
---|---|---|
RSI ODDS (%) | 4 days ago51% | N/A |
Stochastic ODDS (%) | 4 days ago72% | 4 days ago80% |
Momentum ODDS (%) | 4 days ago68% | 4 days ago86% |
MACD ODDS (%) | 4 days ago62% | 4 days ago83% |
TrendWeek ODDS (%) | 4 days ago58% | 4 days ago85% |
TrendMonth ODDS (%) | 4 days ago64% | 4 days ago84% |
Advances ODDS (%) | 4 days ago66% | 15 days ago75% |
Declines ODDS (%) | 6 days ago58% | 5 days ago84% |
BollingerBands ODDS (%) | 4 days ago68% | 4 days ago67% |
Aroon ODDS (%) | 4 days ago62% | 4 days ago80% |
A.I.dvisor indicates that over the last year, GMED has been loosely correlated with VREX. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if GMED jumps, then VREX could also see price increases.
Ticker / NAME | Correlation To GMED | 1D Price Change % | ||
---|---|---|---|---|
GMED | 100% | +0.51% | ||
VREX - GMED | 56% Loosely correlated | -0.09% | ||
CVRX - GMED | 49% Loosely correlated | +1.56% | ||
CTKB - GMED | 49% Loosely correlated | +1.01% | ||
ITGR - GMED | 45% Loosely correlated | +0.32% | ||
BRKR - GMED | 44% Loosely correlated | +3.49% | ||
More |
A.I.dvisor tells us that TELA and HBIO have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TELA and HBIO's prices will move in lockstep.
Ticker / NAME | Correlation To TELA | 1D Price Change % | ||
---|---|---|---|---|
TELA | 100% | N/A | ||
HBIO - TELA | 28% Poorly correlated | +2.20% | ||
BAX - TELA | 27% Poorly correlated | +3.56% | ||
AZTA - TELA | 27% Poorly correlated | +2.64% | ||
BNGO - TELA | 25% Poorly correlated | +9.62% | ||
GMED - TELA | 25% Poorly correlated | +0.51% | ||
More |